Advanced Medical Solutions Group (LON:AMS) Given “Hold” Rating at Deutsche Bank Aktiengesellschaft

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “hold” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Friday,Digital Look reports. They currently have a GBX 275 target price on the stock. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential downside of 1.43% from the company’s current price.

Other analysts have also recently issued reports about the stock. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 260 price target on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Berenberg Bank reiterated a “buy” rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research note on Tuesday, May 19th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 270.25.

Advanced Medical Solutions Group Stock Up 0.2%

LON AMS traded up GBX 0.50 on Friday, reaching GBX 279. 130,497,250 shares of the stock traded hands, compared to its average volume of 3,990,257. The company has a debt-to-equity ratio of 31.50, a quick ratio of 4.58 and a current ratio of 2.79. The company has a fifty day moving average price of GBX 232.88 and a 200-day moving average price of GBX 218.23. The company has a market cap of £606.07 million, a price-to-earnings ratio of 61.73, a PEG ratio of 5.00 and a beta of 0.71. Advanced Medical Solutions Group has a 12 month low of GBX 187 and a 12 month high of GBX 279.50.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.